Dex increased TNF-α and IFN-γ production in splenic T cells and improved cardiac function in a murine model of myocardial infarction (MI), which suggests a novel strategy for the treatment of MI using Dex-based therapeutics [132]. This evidence concerns the gene IFNG and myocardial infarction.